Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change
02/10/26	EUR 0.4750	0.00%
01/10/26	EUR 0.4750	-4.81%
30/09/26	EUR 0.4990	-13.07%
29/09/26	EUR 0.5740	0.00%
28/09/26	EUR 0.5740	-6.51%

Delayed Quote Deutsche Boerse AG

More quotes

Delayed Deutsche Boerse AG 04:00:53 02/10/26 pm AEST			5-day change	1st Jan Change
0.4750 ^EUR	0.00%		-22.64%	-39.41%

03/11	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	2.88M 3.24M 2.69M 2.45M 4.61M 312M 4.68M 32.54M 12.6M 159M 12.16M 11.89M 510M	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	3.96M 4.46M 3.7M 3.37M 6.35M 429M 6.44M 44.77M 17.33M 218M 16.73M 16.36M 702M	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	99.21%	Yield 2023 *	-	Yield 2024	-

Markets		Quality
Euronext Paris	ALKLA	Real-time
Deutsche Boerse AG	4YA	Delayed
Börse Stuttgart	4YA	Delayed
Boerse Muenchen	4YA	Real-time

03/11	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/10/24	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
30/04/24	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03/24	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
08/11/23	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/10/23	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/04/23	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/03/23	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/12/22	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
15/12/22	Twitter to shut down newsletter product Revue next year	RE
06/12/22	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
06/10/22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

Klarsen Stock Deutsche Boerse AG

Stocks

4YA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news: Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Price Extremes

Managers and Directors: Klarsen

Other IT Services & Consulting

Financials

Company Profile

Quotes

04/03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
26/02	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
10/12	Klarsen : ALKLA-Attribution gratuite de BSA	PU
09/12	Klarsen : ALKLA-ACTIVITE 3T2025	PU
28/11	Klarsen : ALKLA-Résultat augmentation de capital	PU

08/09	Klarsen : calendrier de communication
08/09	Klarsen : ALKLA – Klarsen fait évoluer son calendrier de communication financière et rappelle la tenue de ses Assemblées Générales des 29 septembre et 8 octobre 2026 – 08 Septembre 2026
28/08	Klarsen : ALKLA – Présentation webinaire du 27/08/2026 – Support
27/08	Klarsen : Assemblée générale – 29 Septembre 2026
19/08	Bourse : série de résultats en Europe, flambée d'Unitree et puces Nvidia en Chine

1 week	-22.64%
Current month	-4.81%
1 month	-47.46%
3 months	-27.15%
6 months	-37.50%
Current year	-39.41%

1 week	0.48	0.61
1 month	0.48	0.84
Current year	0.2	1.38
1 year	0.2	1.38
3 years	0.2	3.62
5 years	0.2	3.83
10 years	0.2	4.14

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	01/07/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	01/01/2013

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	14/06/2010
Gérard Parrou BRD	Director/Board Member	74	27/06/2014
Frédéric Bartoli BRD	Director/Board Member	-	23/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	0.00%	-22.64%	-	-	2.05M
IBM	+2.59%	-0.63%	-21.25%	+60.81%	213B
SALESFORCE, INC.	+3.10%	-0.64%	+0.42%	+16.72%	195B
CLOUDFLARE, INC.	+1.07%	-2.18%	+61.71%	+456.79%	125B
SNOWFLAKE INC.	+0.72%	+2.39%	+48.34%	+123.86%	121B
ACCENTURE PLC	+15.78%	+19.67%	-12.89%	-30.87%	127B
TATA CONSULTANCY SERVICES LTD.	+1.19%	-0.57%	-28.80%	-41.19%	77.98B
RELX PLC	+0.80%	-0.59%	-28.24%	-9.55%	57.69B
COREWEAVE, INC.	+1.66%	-1.73%	-35.37%	-	48.85B
FUJITSU LIMITED	+1.67%	+1.02%	+19.75%	+131.72%	44.08B
Average	+2.62%	+1.23%	+0.41%	+88.54%	112B
Weighted average by Cap.	+3.41%	+1.05%	+2.72%	+90.02%

	2023	2024
Net sales	5.03M 5.66M 4.7M 4.28M 8.06M 545M 8.17M 56.86M 22.01M 277M 21.25M 20.78M 891M	6.31M 7.11M 5.9M 5.38M 10.13M 684M 10.26M 71.4M 27.64M 348M 26.68M 26.1M 1.12B
Net income	2.75M 3.1M 2.57M 2.34M 4.41M 298M 4.47M 31.12M 12.05M 152M 11.63M 11.38M 488M	-47.76K -53.78K -44.67K -40.71K -76.63K -5.18M -77.69K -540K -209K -2.64M -202K -198K -8.47M
Net Debt	-634K -714K -593K -541K -1.02M -68.78M -1.03M -7.18M -2.78M -35.03M -2.68M -2.62M -113M	1.08M 1.22M 1.01M 921K 1.73M 117M 1.76M 12.23M 4.73M 59.66M 4.57M 4.47M 192M